Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
The WATCHMAN device is designed to be permanently implanted distal to the ostium of the left atrial appendage (LAA) to trap potential emboli before they exit the LAA.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient has paroxysmal, persistent or permanent non-valvular atrial fibrillation (AF)
Eligible for long term warfarin
CHADS score \>= 1 \[congestive heart failure (CHF), history of high blood pressure, 75 years of age or older, diabetes, prior stroke or transient ischemic attack (TIA)\]
You may not be if
Contraindicated for warfarin
Contraindicated for aspirin or clopidogrel (Plavix)
Congestive heart failure (CHF) Class 4
Implanted mechanical valve
Atrial septal or Patent Foramen Ovale (PFO) device
Platelets \< 100,000 or hemoglobin \< 10
Left ventricular ejection fraction (LVEF) \< 30%
Clareo Health | WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation
